Wir sind mit live!
Mehr erfahren
Nutriband Inc Warrant
NTRBW
NTRBW
Nicht mehr börsennotiert
NTRBW wurde am 30. September 2026 von der Börse genommen.
Profil: Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Mitarbeiter: 3
Nachrichten
Positiv
Neutral
Negativ
Stimmung
3 Monate
Positiv
0 %
Neutral
100 %
Negativ
0 %
Kursdiagramme mit Lightweight Charts™ umgesetzt